Isovue-M-200 Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with Isovue-M-200
U
- U-Tri-Lone (triamcinolone)
- UAD Caine (lidocaine)
- ULR-LA (guaifenesin / phenylpropanolamine)
- Ultiva (remifentanil)
- Ultracet (acetaminophen / tramadol)
- Ultram (tramadol)
- Ultram ER (tramadol)
- Ultram ODT (tramadol)
- Uni Bronchial (guaifenesin / theophylline)
- Uni Decon (chlorpheniramine / phenylephrine / phenylpropanolamine / phenyltoloxamine)
- Uni Multihist DM (brompheniramine / dextromethorphan / phenylpropanolamine)
- Uni Serp (hydralazine / hydrochlorothiazide / reserpine)
- Uni Tuss HC (chlorpheniramine / hydrocodone / phenylephrine)
- Uni Tussin CF (dextromethorphan / guaifenesin / phenylpropanolamine)
- Uni-Cof (chlorpheniramine / dihydrocodeine / pseudoephedrine)
- Uni-Cof Expectorant (dihydrocodeine / guaifenesin / pseudoephedrine)
- Uni-Dur (theophylline)
- Uni-Lev 5.0 (guaifenesin / hydrocodone / phenylephrine)
- Uni-Multihist D Ped (pheniramine / phenylpropanolamine / phenyltoloxamine / pyrilamine)
- Uni-Tricof HC (chlorpheniramine / hydrocodone / phenylephrine)
- Uniphyl (theophylline)
- Unipres (hydralazine / hydrochlorothiazide / reserpine)
- Uniretic (hydrochlorothiazide / moexipril)
- ure-Na (urea)
- urea
- Ureaphil (urea)
- Urecholine (bethanechol)
- Uzedy (risperidone)
More about Isovue-M-200 (iopamidol)
- Isovue-M-200 consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Latest FDA alerts (3)
- Side effects
- Dosage information
- During pregnancy
- Drug class: non-ionic iodinated contrast media
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.